CooperCompanies to Present at the J.P. Morgan Healthcare Conference
SAN RAMON, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) — CooperCompanies (Nasdaq: COO), a leading global medical device company, will participate […]
Credicorp LTD.: Credicorp Announces Executive Leadership Changes Effective July 1, 2024
Lima, Dec. 21, 2023 (GLOBE NEWSWIRE) — Lima, PERU, December 21, 2023 — Credicorp Ltd. (“Credicorp” or the “Company”) (NYSE: BAP | […]
Mineralys Therapeutics Announces First Subject Dosed in Launch-HTN, the Second Pivotal Trial of Lorundrostat for the Treatment of Hypertension
– Topline data from confirmatory Launch-HTN trial expected in 2H 2025 – – Topline data from ongoing Advance-HTN pivotal trial […]
Banzai CEO Purchases Additional Shares in Market
SEATTLE, Dec. 21, 2023 (GLOBE NEWSWIRE) — Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology […]
Great Lakes Dredge & Dock Co. Announces Significant Status Update on its Maritime Administration (“MARAD”) Title XI Financing Application
HOUSTON, Dec. 21, 2023 (GLOBE NEWSWIRE) — Great Lakes Dredge & Dock Corporation (“Great Lakes” or the “Company”) (NASDAQ: GLDD), […]
Hudson Acquisition I Corp. Receives Notification from Nasdaq Regarding Minimum Market Value Deficiency
NEW YORK, Dec. 21, 2023 (GLOBE NEWSWIRE) — Hudson Acquisition I Corp. (the “Company” or “Hudson”) (Nasdaq: HUDA), announced today […]
Clarion Clinics Receives Ethics Board Endorsement for the First Dedicated Psychedelic-Assisted Therapy Clinic in Australia
Highlights: Incannex subsidiary, Clarion Clinics, has received Human Research Ethics Committee (HREC) endorsement for administration of psychedelic-assisted therapies for TRD […]
Mission Produce(TM) Announces Fiscal 2023 Fourth Quarter Financial Results
OXNARD, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) — Mission Produce, Inc. (Nasdaq: AVO) (“Mission” or the “Company”), a world leader […]
Topline Results from MYLOX-1 Trial Demonstrate Reduction in Fibrosis of the Bone Marrow in Patients with Myelofibrosis
BOSTON, Dec. 21, 2023 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical stage biotechnology company focused on the development […]
Seer to Present at the J.P. Morgan 42nd Annual Health Care Conference
REDWOOD CITY, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a […]
